mass spectrometry comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.
Last reviewed on 2026-07-25. Where a claim depends on a specific study, the study is described rather than over-claimed.
Cloudiness, particles, or gel formation after reconstitution can signal incomplete dissolution, aggregation, or contamination. A clear solution is not proof of purity, and a cloudy one is not always unusable if the peptide is designed to form suspensions. pH measurement can identify whether the solution matches the intended range, and buffer exchange may be needed when the original solvent is incompatible. Sterile filtration is sometimes used for microbial control, but filters can adsorb peptides and reduce concentration. Documentation of lot number, solvent, volume, date, and storage condition supports later traceability in laboratory records.
Once a peptide is in liquid form, its stability depends on temperature, pH, concentration, and the presence of oxygen or microbes. Refrigeration slows many degradation pathways, while freezing can extend storage for longer periods. Repeated freeze-thaw cycles are generally avoided because ice crystal formation and concentration changes can promote aggregation. Light exposure can also damage peptides that contain aromatic or sulfur-containing residues. A common laboratory practice is to divide a reconstituted stock into single-use aliquots before freezing, but the optimal storage condition remains peptide-specific and is often determined empirically.
Analytical checks help determine whether a reconstituted peptide matches its expected identity and purity; reverse-phase high-performance liquid chromatography separates components by hydrophobicity and can reveal degradation products or impurities. Mass spectrometry provides a mass measurement that supports sequence identity when compared with the theoretical value. Ultraviolet absorbance at 280 nm can estimate concentration for peptides containing tryptophan or tyrosine, though sequence-dependent extinction coefficients are needed. For shorter or non-aromatic peptides, other methods such as amino acid analysis may be required. These techniques describe the material rather than guarantee its biological effect.
Storage conditions for reconstituted peptides are product-specific. Cool temperatures slow many degradation pathways, but freezing can concentrate solutes and promote aggregation. Light exposure can oxidize susceptible residues such as methionine, cysteine, or tryptophan. Oxygen in headspace can contribute to oxidation, while acidic or basic pH can drive hydrolysis and deamidation. The best storage condition for a given sequence is often determined empirically because general rules do not capture all sequence-specific effects.
Quality control of reconstituted peptides combines visual inspection with instrumental analysis. A clear solution does not prove correct identity or purity, and a cloudy solution does not always indicate failure. Reverse-phase high-performance liquid chromatography can separate the peptide from related impurities, while mass spectrometry confirms molecular mass and detects modifications. pH measurement and osmolality checks provide additional information about the solution environment, and documentation of lot number, solvent, and storage history supports traceability.
| Property | Value | Notes |
|---|---|---|
| Lyophilized storage temperature | -20 °C or lower | Desiccant and sealed vial limit moisture exposure. |
| Reconstituted short-term storage | 2 to 8 °C | Refrigeration slows degradation for many peptides. |
| Reconstituted long-term storage | -20 °C or lower | Aliquoting before freezing limits freeze-thaw cycles. |
| Common identity method | LC-MS | Measured mass is compared with the theoretical peptide mass. |
| Common purity method | RP-HPLC | Separation reveals related impurities and degradation products. |
There are debates over other potential causes such as nighttime drops in blood pressure, as well as the hypothesis that the optic disc's ability to regulate its blood flow may be compromised. Some researchers have even suggested that blockages in the veins could be responsible. One hypothesis suggests that the underlying cause may be a subtle decrease in blood flow to the optic nerve, which is enough to cause swelling of the nerve fibers but not severe enough to disrupt vision through tissue death and permanent damage to the optic nerve. When considering the possible causes for spontaneous NAION, the list includes other conditions like arteritic anterior ischemic optic neuropathy (associated with inflammation of arteries), optic neuritis (inflammation of the optic nerve), infiltrative and compressive types of optic neuropathy (where the optic nerve is invaded or pressed upon by abnormal substances or structures), diabetic papillopathy (swelling of the optic disc in diabetes), radiation-induced damage to the optic nerve, neuroretinitis (inflammation of the optic nerve and retina), and swelling of the optic disc linked with retinal diseases like central retinal vein occlusion.
== Preparation == The compound is prepared by reacting 4-tert-butylbenzoic methyl ester (from 4-tert-butylbenzoic acid by esterification with methanol) with 4-methoxyacetophenone in toluene in the presence of sodium amide via Claisen condensation.
The definition of the topical route of administration sometimes states that both the application location and the pharmacodynamic effect thereof is local. In other cases, topical is defined as applied to a localized area of the body or to the surface of a body part regardless of the location of the effect. By this definition, topical administration also includes transdermal application, where the substance is administered onto the skin but is absorbed into the body to attain systemic distribution. If defined strictly as having local effect, the topical route of administration can also include enteral administration of medications that are poorly absorbable by the gastrointestinal tract. One such medication is the antibiotic vancomycin, which cannot be absorbed in the gastrointestinal tract and is used orally only as a treatment for Clostridioides difficile colitis.
== Biosynthesis == Lariocidin is a 18 amino acid-long peptide with the sequence SKKSKPGDGKFGRGVKRG, whose N-terminal serine forms an isopeptide bond with the side chain of aspartate 8 and the C-terminal tail is threaded through the loop formed. Lariocidin belongs to the lasso peptide family of the ribosomally synthesized and post-translationally modified peptide (RiPP) class of natural products. Lariocidin biosynthetic gene cluster (BGC) in the genome of the producer encodes a precursor peptide (LrcA), the enzymes required for its modification (LrcB1B2C), export pumps (LrcD1D2), and a self-resistance acetyltransferase LrcE. The biosynthetic machinery installs a characteristic isopeptide bond that creates the macrocycle and generates the threaded, “lasso” topology. In the same BGC researchers identified a peptidase LrcF, whose activity is required for the formation of the LAR-B variant - an internally cyclized derivative of LAR. Heterologous expression of the lariocidin BGC in model host and targeted gene deletion supported the proposed functions of the encoded proteins.
Sources: en.wikipedia.org
Diabetes mellitus similar but not identical to human Type I (insulin deficiency): The disease occurs in middle-aged Samoyeds, the mean age at diagnosis is seven years. The cause is a chronic inflammation of the pancreas and/or autoimmune destruction of the beta cells of islets of Langerhans. Moreover, autoantibodies to insulin were found in affected dogs. Several genetic markers are being discussed as possible causes. Progressive retinal atrophy (PRA) caused by a frameshift mutation in the RPRG locus of the X chromosome. The disease leads to a slowly progressive loss of vision, which eventually leads to blindness. The first symptoms appear between two and five years of age. The disease corresponds to the X-linked PRA type 3 in humans. Short legs in conjunction with eye abnormalities: a genetic defect at the COL2A1 locus leads to disproportionate dwarfism due to short limbs in connection with cataracts, malformations of the retina or retinal detachment, liquefaction of the vitreous and a persistent hyaloid artery. The malformations of the retina are dominant (i.e. they occur in heterozygous dogs); the other symptoms are recessive, so that they are expressed only in homozygous dogs. These conditions have no effect on the expression of the protein opticin. Pulmonary stenosis occurs more frequently in Samoyeds in comparison with other breeds. The disease can cause shortness of breath, cardiac arrhythmias and rapid fatigue when moving, and increases the risk of congestive heart failure. Hip dysplasia is also a concern for Samoyeds.
== Causes == No clear cause for scleroderma and systemic sclerosis has been identified. Genetic predisposition appears to be limited, as genetic concordance is small; still, a familial predisposition for autoimmune disease is often seen. Polymorphisms in COL1A2 and TGF-β1 may influence severity and development of the disease. Evidence implicating cytomegalovirus (CMV) as the original epitope of the immune reaction is limited, as is parvovirus B19. Organic solvents and other chemical agents have been linked with scleroderma. One of the suspected mechanisms behind the autoimmune phenomenon is the existence of microchimerism, i.e. fetal cells circulating in maternal blood, triggering an immune reaction to what is perceived as foreign material. A distinct form of scleroderma and systemic sclerosis may develop in patients with chronic kidney failure. This form, nephrogenic fibrosing dermopathy or nephrogenic systemic fibrosis, has been linked to exposure to gadolinium-containing radiocontrast. Bleomycin (a chemotherapeutic agent) and possibly taxane chemotherapy may cause scleroderma, and occupational exposure to solvents has been linked to an increased risk of systemic sclerosis.
=== Negative selection and the role of the thymus === The elimination of self-reactive T cells occurs primarily through a mechanism known as "negative selection" within the thymus, an organ responsible for the maturation of T cells. This process serves as a key line of defense against autoimmunity. If these protective mechanisms fail, a pool of self-reactive cells can become functional within the immune system, contributing to the development of autoimmune diseases.
Sources: en.wikipedia.org
===== Strain promoted Huisgen cyclization of azides ===== Even though Staudinger ligation is a suitable bioconjugation in living cells without major toxicity, the phosphine's sensitivity to air oxidation and its poor solubility in water significantly hinder its efficiency. The copper(I) catalyzed azide-alkyne coupling has reasonable reaction rate and efficiency under physiological conditions, but copper poses significant toxicity and sometimes interferes with protein functions in living cells. In 2004, chemist Carolyn R. Bertozzi's lab developed a metal free [3+2] cycloaddition using strained cyclooctyne and azide. Cyclooctyne, which is the smallest stable cycloalkyne, can couple with azide through [3+2] cycloaddition, leading to two regioisomeric triazoles (Figure 12). The reaction occurs readily at room temperature and therefore can be used to effectively modify living cells without negative effects. It has also been reported that the installation of fluorine substituents on a cyclic alkyne can greatly accelerate the reaction rate.
Bernoulli's principle is a concept in fluid dynamics that relates pressure, speed and height. For example, for a fluid flowing horizontally, Bernoulli's principle states that an increase in the speed occurs simultaneously with a decrease in pressure. The principle is named after the Swiss mathematician and physicist Daniel Bernoulli, who published it in his book Hydrodynamica in 1738. Although Bernoulli deduced that pressure decreases when the flow speed increases, it was Leonhard Euler in 1752 who derived Bernoulli's equation in its usual form. Bernoulli's principle can be derived directly from Isaac Newton's second law of motion. When a small volume of fluid is flowing horizontally from a region of high pressure to a region of low pressure, there is more pressure from behind than in front. This gives a net force on the volume, accelerating it along the streamline. If the pressure is decreasing along the streamline, the fluid is accelerated and the speed increases. Thus the decrease of pressure is the cause of a higher speed. Similarly, if the pressure is increasing, the speed decreases. Bernoulli's principle can also be derived from the principle of conservation of energy. In a steady fluid flow the total of all forms of energy is conserved. This requires that the sum of kinetic energy, potential energy and internal energy remains constant. Thus an increase in the kinetic energy of the fluid occurs with a simultaneous decrease in its potential energy and internal energy.
=== Acromegaly === Acromegaly is a syndrome caused by the anterior pituitary gland producing excess growth hormone (GH). A number of disorders may increase the pituitary's GH output, although most commonly it involves a tumor called pituitary adenoma, derived from a distinct type of cell (somatotrophs). It leads to anatomical changes and metabolic dysfunction caused by elevated GH and IGF1 levels. High level of IGF1 in acromegaly is related to an increased risk of some cancers, particularly colon cancer and thyroid cancer.
==== Phenotypic drug discovery ==== Phenotypic drug discovery is a traditional drug discovery method, also known as forward pharmacology or classical pharmacology. It uses the process of phenotypic screening on collections of synthetic small molecules, natural products, or extracts within chemical libraries to pinpoint substances exhibiting beneficial therapeutic effects. This method is to first discover the in vivo or in vitro functional activity of drugs (such as extract drugs or natural products), and then perform target identification. Phenotypic discovery uses a practical and target-independent approach to generate initial leads, aiming to discover pharmacologically active compounds and therapeutics that operate through novel drug mechanisms. This method allows the exploration of disease phenotypes to find potential treatments for conditions with unknown, complex, or multifactorial origins, where the understanding of molecular targets is insufficient for effective intervention.
Sources: en.wikipedia.org
Short-term storage is often under refrigeration, while longer storage may use freezing at -20 °C or lower. The choice depends on peptide stability and the solvent. Dividing the solution into aliquots reduces repeated temperature changes.
Mass spectrometry is used to compare the measured mass with the expected mass. Reverse-phase liquid chromatography can assess purity and detect degradation products. These methods are complementary and do not replace one another.
Cloudiness may come from incomplete dissolution, aggregated peptide, undissolved salts, or microbial growth. Some peptides are intentionally formulated as suspensions rather than clear solutions. The cause is often determined by inspecting the solvent, pH, and preparation history.
There is no universal storage time because stability depends on sequence, solvent, pH, concentration, and temperature. Product-specific data or stability studies provide the most reliable guidance. In the absence of such data, short-term cold storage is common.